PAINCHEK LTD - Announcements

6.12%

5.2¢

Market Cap $107.2M

Technology Software - Application

PainChek Ltd is an Australia-based company, which develops pain assessment technologies.... PainChek Ltd is an Australia-based company, which develops pain assessment technologies. The Company's principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. The Company's PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the NRS, a standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PCK	New Peer reviewed published study	PRICE SENSITIVE	29/01/18	683.84KB	Share
PCK	PainChek Head of Business Development ANZ Appointment		22/01/18	683.17KB	Share
PCK	Change of Company Name to PainChek Ltd		17/01/18	658.22KB	Share
PCK	Certificate of Registration on Change of Name		17/01/18	449.11KB	Share
PCK	Results of Meeting		17/01/18	752.72KB	Share
PCK	Appendix 3B and Cleansing Notice		21/12/17	1.54MB	Share
PCK	Company name change to PainChek Ltd		15/12/17	696.88KB	Share
PCK	Notice of General Meeting/Proxy Form		15/12/17	515.5KB	Share
PCK	Appendix 3B and Cleansing Notice		13/12/17	1.57MB	Share
PCK	2nd peer-review confirms excellent performance of PainChek	PRICE SENSITIVE	13/12/17	688.84KB	Share
PCK	Results of Meeting		21/11/17	793.16KB	Share
PCK	AGM Presentation		21/11/17	2.54MB	Share
PCK	PainChek Childrens App Commercialization Timelines on Track		15/11/17	658.24KB	Share
PCK	ePAT and PainChek continue to achieve commercial milestones	PRICE SENSITIVE	08/11/17	791.61KB	Share
PCK	Quarterly Update and Appendix 4C	PRICE SENSITIVE	31/10/17	1.07MB	Share
PCK	Appendix 3B and Cleansing Notice		25/10/17	1.57MB	Share
PCK	Appendix 3B and Cleansing Notice		20/10/17	1.57MB	Share
PCK	Notice of Annual General Meeting/Proxy Form		13/10/17	852.09KB	Share
PCK	Appendix 4G and Corporate Governance Statement		12/10/17	482.25KB	Share
PCK	Annual Report to shareholders		12/10/17	3.34MB	Share
PCK	PainChek trademark and branding supports commercialisation		10/10/17	805.65KB	Share
PCK	ePAT accelerates commercialisation at Alzheimers Conference		26/09/17	861.69KB	Share
PCK	Cleansing Notice		20/09/17	714.1KB	Share
PCK	Appendix 3B		20/09/17	874.34KB	Share
PCK	Release of Securities from Escrow		18/09/17	656.96KB	Share
PCK	Placement to raise $3.75 million	PRICE SENSITIVE	18/09/17	766.83KB	Share
PCK	Trading Halt	PRICE SENSITIVE	14/09/17	731.97KB	Share
PCK	Appendix 3B		08/09/17	861.27KB	Share
PCK	Allotment of Deferred Consideration Shares		08/09/17	688.91KB	Share
PCK	Core strategic agreement with Dementia Support Australia	PRICE SENSITIVE	07/09/17	575.98KB	Share
PCK	Full Year Statutory Accounts		29/08/17	1.4MB	Share
PCK	Preliminary Final Report	PRICE SENSITIVE	29/08/17	395.05KB	Share
PCK	ePAT Clinical Study Published in Alzheimer's Disease Journal	PRICE SENSITIVE	15/08/17	575.26KB	Share
PCK	Response to ASX Price Query	PRICE SENSITIVE	14/08/17	815.34KB	Share
PCK	Appendix 3B		07/08/17	894KB	Share
PCK	Quarterly Update and Appendix 4C	PRICE SENSITIVE	31/07/17	988.21KB	Share
PCK	nViso agrees perpetual global license, takes strategic stake	PRICE SENSITIVE	24/07/17	874.03KB	Share
PCK	Response to ASX query	PRICE SENSITIVE	24/07/17	929.14KB	Share
PCK	Appendix 3B		24/07/17	874.08KB	Share
PCK	Investor Presentation		19/07/17	1.56MB	Share
PCK	ePAT Pain Assessment App Secures Regulatory Clearance	PRICE SENSITIVE	19/07/17	776.54KB	Share
PCK	New Study Validates Face Recognition App in Pain Detection	PRICE SENSITIVE	04/07/17	1.47MB	Share
PCK	Investor Presentation		21/06/17	1.8MB	Share
PCK	Appendix 3B		11/05/17	865.8KB	Share
PCK	Third Quarter Report FY 2016/17		28/04/17	734.52KB	Share
PCK	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	233.01KB	Share
PCK	1st version iOS App Introduced at Pain Society Conference		11/04/17	727.08KB	Share
PCK	Appendix 3B		05/04/17	867.46KB	Share
PCK	Appointment of Chief Technology Officer		03/04/17	714.64KB	Share
PCK	Expiry of listed options		31/03/17	977.26KB	Share
PCK	Launch of IBM Case Study	PRICE SENSITIVE	15/03/17	713.93KB	Share
PCK	Appendix 3B		13/03/17	864.41KB	Share
PCK	Investor Presentation		06/03/17	3.03MB	Share
PCK	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/17	851.63KB	Share
PCK	Second Quarter Report FY 2016/17	PRICE SENSITIVE	30/01/17	171.03KB	Share
PCK	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/17	233.11KB	Share
PCK	Change of Director Interest Notices x 4		20/12/16	980.16KB	Share
PCK	Appendix 3B		19/12/16	866.74KB	Share
PCK	Market Update	PRICE SENSITIVE	14/12/16	933.17KB	Share
PCK	Results of Meeting		23/11/16	668.53KB	Share
PCK	Market Update-EPT.AX	PRICE SENSITIVE	02/11/16	698.13KB	Share
PCK	Quarterly Review and Appendix 4C-EPT.AX	PRICE SENSITIVE	31/10/16	1MB	Share
PCK	Notice of Annual General Meeting/Proxy Form-EPT.AX		20/10/16	464.96KB	Share
PCK	Confirmations-EPT.AX		18/10/16	996.97KB	Share
PCK	Terms and Conditions of Options issued to Promoters-EPT.AX		18/10/16	316.7KB	Share
PCK	Terms and Conditions of Options issued to Noteholders-EPT.AX		18/10/16	319.98KB	Share
PCK	Corporate Governance Statement-EPT.AX		18/10/16	181.94KB	Share
PCK	Securities Trading Policy-EPT.AX		18/10/16	590.9KB	Share
PCK	Updated Pro-Forma Financial Position-EPT.AX		18/10/16	352.14KB	Share
PCK	Updated Statement of Commitments-EPT.AX		18/10/16	166.83KB	Share
PCK	Accounts for the period ended 30 June 2016-EPT.AX		18/10/16	744.32KB	Share
PCK	Accounts for the period ended 30 June 2015-EPT.AX		18/10/16	668.22KB	Share
PCK	Constitution-EPT.AX		18/10/16	248.24KB	Share
PCK	Updated Capital Structure and Escrow-EPT.AX		18/10/16	193.3KB	Share
PCK	Top 20 Shareholders and Optionholders-EPT.AX		18/10/16	638KB	Share
PCK	Distribution Schedule-EPT.AX		18/10/16	131.28KB	Share
PCK	Information Form and Checklist-EPT.AX		18/10/16	389.33KB	Share
PCK	Appendix 1A-EPT.AX		18/10/16	306.16KB	Share
PCK	ASX Market Release - Pre-reinstatement disclosure-EPT.AX		18/10/16	87.51KB	Share
PCK	ASX Notice - Reinstatement to Official List-EPT.AX		18/10/16	86.93KB	Share
PCK	Reinstatement to Official List - 19/10/2016-EPT.AX	PRICE SENSITIVE	18/10/16	82.14KB	Share

PCK New Peer reviewed published study
29/01/18	PRICE SENSITIVE	683.84KB	Share
PCK PainChek Head of Business Development ANZ Appointment
22/01/18		683.17KB	Share
PCK Change of Company Name to PainChek Ltd
17/01/18		658.22KB	Share
PCK Certificate of Registration on Change of Name
17/01/18		449.11KB	Share
PCK Results of Meeting
17/01/18		752.72KB	Share
PCK Appendix 3B and Cleansing Notice
21/12/17		1.54MB	Share
PCK Company name change to PainChek Ltd
15/12/17		696.88KB	Share
PCK Notice of General Meeting/Proxy Form
15/12/17		515.5KB	Share
PCK Appendix 3B and Cleansing Notice
13/12/17		1.57MB	Share
PCK 2nd peer-review confirms excellent performance of PainChek
13/12/17	PRICE SENSITIVE	688.84KB	Share
PCK Results of Meeting
21/11/17		793.16KB	Share
PCK AGM Presentation
21/11/17		2.54MB	Share
PCK PainChek Childrens App Commercialization Timelines on Track
15/11/17		658.24KB	Share
PCK ePAT and PainChek continue to achieve commercial milestones
08/11/17	PRICE SENSITIVE	791.61KB	Share
PCK Quarterly Update and Appendix 4C
31/10/17	PRICE SENSITIVE	1.07MB	Share
PCK Appendix 3B and Cleansing Notice
25/10/17		1.57MB	Share
PCK Appendix 3B and Cleansing Notice
20/10/17		1.57MB	Share
PCK Notice of Annual General Meeting/Proxy Form
13/10/17		852.09KB	Share
PCK Appendix 4G and Corporate Governance Statement
12/10/17		482.25KB	Share
PCK Annual Report to shareholders
12/10/17		3.34MB	Share
PCK PainChek trademark and branding supports commercialisation
10/10/17		805.65KB	Share
PCK ePAT accelerates commercialisation at Alzheimers Conference
26/09/17		861.69KB	Share
PCK Cleansing Notice
20/09/17		714.1KB	Share
PCK Appendix 3B
20/09/17		874.34KB	Share
PCK Release of Securities from Escrow
18/09/17		656.96KB	Share
PCK Placement to raise $3.75 million
18/09/17	PRICE SENSITIVE	766.83KB	Share
PCK Trading Halt
14/09/17	PRICE SENSITIVE	731.97KB	Share
PCK Appendix 3B
08/09/17		861.27KB	Share
PCK Allotment of Deferred Consideration Shares
08/09/17		688.91KB	Share
PCK Core strategic agreement with Dementia Support Australia
07/09/17	PRICE SENSITIVE	575.98KB	Share
PCK Full Year Statutory Accounts
29/08/17		1.4MB	Share
PCK Preliminary Final Report
29/08/17	PRICE SENSITIVE	395.05KB	Share
PCK ePAT Clinical Study Published in Alzheimer's Disease Journal
15/08/17	PRICE SENSITIVE	575.26KB	Share
PCK Response to ASX Price Query
14/08/17	PRICE SENSITIVE	815.34KB	Share
PCK Appendix 3B
07/08/17		894KB	Share
PCK Quarterly Update and Appendix 4C
31/07/17	PRICE SENSITIVE	988.21KB	Share
PCK nViso agrees perpetual global license, takes strategic stake
24/07/17	PRICE SENSITIVE	874.03KB	Share
PCK Response to ASX query
24/07/17	PRICE SENSITIVE	929.14KB	Share
PCK Appendix 3B
24/07/17		874.08KB	Share
PCK Investor Presentation
19/07/17		1.56MB	Share
PCK ePAT Pain Assessment App Secures Regulatory Clearance
19/07/17	PRICE SENSITIVE	776.54KB	Share
PCK New Study Validates Face Recognition App in Pain Detection
04/07/17	PRICE SENSITIVE	1.47MB	Share
PCK Investor Presentation
21/06/17		1.8MB	Share
PCK Appendix 3B
11/05/17		865.8KB	Share
PCK Third Quarter Report FY 2016/17
28/04/17		734.52KB	Share
PCK Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	233.01KB	Share
PCK 1st version iOS App Introduced at Pain Society Conference
11/04/17		727.08KB	Share
PCK Appendix 3B
05/04/17		867.46KB	Share
PCK Appointment of Chief Technology Officer
03/04/17		714.64KB	Share
PCK Expiry of listed options
31/03/17		977.26KB	Share
PCK Launch of IBM Case Study
15/03/17	PRICE SENSITIVE	713.93KB	Share
PCK Appendix 3B
13/03/17		864.41KB	Share
PCK Investor Presentation
06/03/17		3.03MB	Share
PCK Half Yearly Report and Accounts
22/02/17	PRICE SENSITIVE	851.63KB	Share
PCK Second Quarter Report FY 2016/17
30/01/17	PRICE SENSITIVE	171.03KB	Share
PCK Appendix 4C - quarterly
30/01/17	PRICE SENSITIVE	233.11KB	Share
PCK Change of Director Interest Notices x 4
20/12/16		980.16KB	Share
PCK Appendix 3B
19/12/16		866.74KB	Share
PCK Market Update
14/12/16	PRICE SENSITIVE	933.17KB	Share
PCK Results of Meeting
23/11/16		668.53KB	Share
PCK Market Update-EPT.AX
02/11/16	PRICE SENSITIVE	698.13KB	Share
PCK Quarterly Review and Appendix 4C-EPT.AX
31/10/16	PRICE SENSITIVE	1MB	Share
PCK Notice of Annual General Meeting/Proxy Form-EPT.AX
20/10/16		464.96KB	Share
PCK Confirmations-EPT.AX
18/10/16		996.97KB	Share
PCK Terms and Conditions of Options issued to Promoters-EPT.AX
18/10/16		316.7KB	Share
PCK Terms and Conditions of Options issued to Noteholders-EPT.AX
18/10/16		319.98KB	Share
PCK Corporate Governance Statement-EPT.AX
18/10/16		181.94KB	Share
PCK Securities Trading Policy-EPT.AX
18/10/16		590.9KB	Share
PCK Updated Pro-Forma Financial Position-EPT.AX
18/10/16		352.14KB	Share
PCK Updated Statement of Commitments-EPT.AX
18/10/16		166.83KB	Share
PCK Accounts for the period ended 30 June 2016-EPT.AX
18/10/16		744.32KB	Share
PCK Accounts for the period ended 30 June 2015-EPT.AX
18/10/16		668.22KB	Share
PCK Constitution-EPT.AX
18/10/16		248.24KB	Share
PCK Updated Capital Structure and Escrow-EPT.AX
18/10/16		193.3KB	Share
PCK Top 20 Shareholders and Optionholders-EPT.AX
18/10/16		638KB	Share
PCK Distribution Schedule-EPT.AX
18/10/16		131.28KB	Share
PCK Information Form and Checklist-EPT.AX
18/10/16		389.33KB	Share
PCK Appendix 1A-EPT.AX
18/10/16		306.16KB	Share
PCK ASX Market Release - Pre-reinstatement disclosure-EPT.AX
18/10/16		87.51KB	Share
PCK ASX Notice - Reinstatement to Official List-EPT.AX
18/10/16		86.93KB	Share
PCK Reinstatement to Official List - 19/10/2016-EPT.AX
18/10/16	PRICE SENSITIVE	82.14KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.2¢		Change 0.003(6.12%)		Mkt cap ! $107.2M

Open	High	Low	Value	Volume
5.2¢	5.3¢	5.1¢	$112.9K	2.185M

Buyers (Bids)

No.	Vol.	Price($)
2	102823	5.1¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	659984	4

View Market Depth

No.	Vol.	Price($)
2	102823	0.051
9	924032	0.050
5	572110	0.049
1	210000	0.048
5	468078	0.047

Price($)	Vol.	No.
0.052	659984	4
0.053	687690	5
0.054	1116981	6
0.055	1464189	7
0.056	305000	2

Last trade - 16.10pm 17/09/2025 (20 minute delay)

PCK (ASX) Chart

PAINCHEK LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available